51 results
424B5
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Prospectus supplement for primary offering
4:32pm
to recruit and retain key personnel;
the potential effects of the COVID-19 pandemic on our operations;
our expected use of proceeds from any offering under
424B5
LCTX
Lineage Cell Therapeutics Inc
6 Feb 24
Prospectus supplement for primary offering
9:25am
the proprietary rights of third parties;
our ability to recruit and retain key personnel;
the potential effects of the COVID-19 pandemic on our operations
424B5
n86bfaer3z
21 Dec 21
Prospectus supplement for primary offering
6:05am
424B5
wpl9z4c5 2fq16ygf
5 Mar 21
Prospectus supplement for primary offering
5:15pm